| Financial Year |
March 31 2023 |
| Monetary Funds |
461,124,631.78 |
| Held-for-trading Financial Assets |
35,000,000.00 |
| Notes Receivable |
215,028,421.49 |
| Accounts Receivable |
793,904,480.19 |
| Advances to Suppliers |
46,217,131.93 |
| Other Receivables |
27,358,190.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
878,690,380.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,491,054.16 |
| Total Current Assets |
2,556,407,291.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
42,686,052.64 |
| Fixed Assetes |
1,094,355,771.21 |
| Under-construction Projects |
124,889,675.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
238,590,401.39 |
| R&D expenses |
-- |
| Goodwill |
374,201,597.99 |
| Long-Term Deferred and Prepaid Expenses |
16,741,377.29 |
| Deferred Income Tax Assets |
29,449,024.16 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,027,019,341.79 |
| Total Assets |
4,583,426,632.90 |
| Short-Term Loans |
828,691,513.86 |
| Trading Financial liabilities |
348,769.56 |
| Notes Payable |
293,434,144.16 |
| Accounts Payable |
518,616,380.31 |
| Accounts Received In Advance |
715,744.20 |
| Employee Compensation Payable |
49,295,750.20 |
| Taxes Payable |
16,335,154.99 |
| Interest Payable |
-- |
| Dividend Payable |
6,050,000.00 |
| Other payables |
44,807,925.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
119,667,029.78 |
| Other Current Liabilities |
317,001.81 |
| Sub-Total of Current Liabilities |
1,874,667,889.88 |
| Long-term Loans |
197,224,526.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
25,346,926.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
304,272,072.03 |
| Total Liabilities |
2,178,939,961.91 |
| Paid-In Capital(Or Share Stock) |
328,483,621.00 |
| Capital Surplus |
1,234,772,626.87 |
| Surplus Reserve |
96,427,277.11 |
| LESS:Treasury Stock |
23,741,806.20 |
| Undistributed Profits |
671,376,185.64 |
| Minority Stockholder's Interest |
74,070,314.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,330,416,356.41 |
| Owner's Equity（Stockholder's Equity） |
2,404,486,670.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,583,426,632.90 |
